Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Advisor to its Board and Chair of its R and D Committee
Read Article
News
2024
2023
Archive
Search news articles
August 9, 2018
Viveve Reports Second Quarter 2018 Financial Results and Provides Corporate Update
August 9, 2018
CIDARA PROVIDES CORPORATE UPDATE AND REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS
August 7, 2018
AKOUOS RAISES $50 MILLION SERIES A FINANCING AND EXPANDS TEAM TO ADVANCE PRECISION GENETIC THERAPIES THAT RESTORE AND PRESERVE HEARING
August 7, 2018
Audentes Therapeutics Reports Second Quarter 2018 Financial Results and Provides Update on ASPIRO, the Phase 1/2 Clinical Trial of AT132 in Patients with X-Linked Myotubular Myopathy
August 7, 2018
Nohla Therapeutics Receives FDA Fast Track Designation for Dilanubicel for Allogeneic Cord Blood Transplant Patients
July 31, 2018
Promotions and team expansion!
August 1, 2018
CRINETICS PHARMACEUTICALS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING
July 31, 2018
NOHLA ANNOUNCES THE HIRING OF DR. SARAH NOONBERG AS CMO AND APPOINTMENT OF DR. COLLEEN DELANEY AS CSO
July 16, 2018
Nohla Therapeutics Receives FDA Orphan Drug Designation for Dilanubicel for Hematopoietic Stem Cell Transplant Patients
July 12, 2018
Nohla Therapeutics Announces Second Closing of $56 Million Series B Financing
« Previous Page
1
…
59
60
61
62
63
…
103